Quick Dispatch:
Your glp-1 receptor agonists in idiopathic intracranial hypertension The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp-1 receptor agonists in idiopathic intracranial hypertension The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis ships.
Need Help?
Questions about glp-1 receptor agonists in idiopathic intracranial hypertension The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp-1 receptor agonists in idiopathic intracranial hypertension The effect of GLP-1 agonist on idiopathic intracranial hypertension: a systematic review and meta-analysis in your area.
Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension | The Journal of Headache and Pain
24.68
Efficacy of glucagon-like peptide-1 receptor agonists in idiopathic intracranial hypertension: A systematic review and meta-analysis
27.81
GLP-1 receptor agonists may improve outcomes in idiopathic intracranial hypertension
22.19
GLP-1 Receptor Agonists Significantly Improve Effects of Idiopathic Intracranial Hypertension
26.26
Journal club: GLP-1 receptor agonists in idiopathic intracranial hypertension
23.25
A retrospective cohort study assessed outcomes among patients with idiopathic intracranial hypertension who received glucagon-like peptide-1 receptor agonists
20.76
Abstract 447: GLP‐1 Receptor Agonists and Idiopathic Intracranial Hypertension: A Propensity Score‐Matched Study
25.85
